Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 576-580

  Dominguez Rodriguez, Alberto ^a   Kaski, Juan Carlos ^b   Abreu Gonzalez, Pedro ^c   Samimi Fard, Sima ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Electrocardiography; Ischemia modified albumin; Percutaneous coronary intervention; ST segment elevation myocardial infarction; ST segment resolution

Indexed keywords

BIOLOGICAL MARKER; ISCHEMIA MODIFIED ALBUMIN;

AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REPERFUSION; SENSITIVITY AND SPECIFICITY; ST SEGMENT; ST SEGMENT ELEVATION;

AGED; ALBUMINS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPERFUSION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 62649175720     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.07.033     Document Type: Article

References (29)

1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
2. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
3. Van't Hof A.W., Liem A., de Boer M.J., and Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350 (1997) 615-619
4. Iliceto S., Marangelli V., Marchese A., et al. Myocardial contrast echocardiography in acute myocardial infarction: pathophysiological background and clinical application. Eur Heart J 17 (1997) 344-353
5. Van't Hof A.W., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade. Circulation 97 (1998) 2302-2306
6. De Lemos J.A., and Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 38 (2001) 1283-1294
7. Pepine C.J. Prognostic markers in thrombolytic therapy: looking beyond mortality. Am J Cardiol 78 (1996) 24-27
8. Angeja B.G., Gunda M., Murphy S.A., et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 105 (2002) 282-285
9. Zeymer U., Schroder K., Wegscheider K., et al. ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction. Am Heart J 149 (2005) 91-97
10. De Lemos J.A., Antman E.M., Giugliano R.P., et al. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. Am Heart J 140 (2000) 373-378
11. Morrow D.A., De Lemos J.A., Sabatine M.S., and Antman E.M. The search for a biomarker of cardiac ischemia. Clin Chem 49 (2003) 537-539
12. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., and Kaski J.C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
13. Sinha M.K., Vasquez J.M., Calvino R., et al. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 92 (2006) 1852-1853
14. Schroder R., Zeymer U., Wegscheider K., and Neuhaus K.L. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. Eur Heart J 20 (1999) 1563-1571
15. McLaughlin M.G., et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction. The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 6 (2004) 1215-1223
16. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19 (2000) 311-315
17. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
18. Hohnloser S., Zabel M., Kasper W., Meinertz T., and Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction using the combined analysis of three noninvasive markers. J Am Coll Cardiol 18 (1991) 44-49
19. De Lemos J.A., Antman E.M., Morrow D.A., et al. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 298 (2000) 85-97
20. De Lemos J.A., et al. Thrombosis In Myocardial Infarction. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol 88 (2001) 353-358
21. Roy D., Quiles J., Sinha M., et al. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93 (2004) 366-368
22. Sinha M.K., Roy D., Gaze D.C., Collinson P.O., and Kaski J.C. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 (2004) 29-34
23. Quiles J., Roy D., Gaze D., et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92 (2003) 322-324
24. Garrido I.P., Roy D., Calvino R., et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 93 (2004) 88-90
25. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., Samimi-Fard S., and Kaski J.C. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta. 388 (2008) 196-199
26. Roy D., and Kaski J.C. Ischemia-modified albumin: the importance of oxidative stress. J Am Coll Cardiol 49 (2007) 2375-2376
27. Roy D., Quiles J., Gaze D., et al. Role of reactive oxygen species in the formation of the novel diagnostic marker ischemia modified albumin. Heart 92 (2006) 113-114
28. Bar-Or D., Rael L.T., Bar-Or R., et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387 (2008) 120-127
29. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190